PartitionBio

PartitionBio is a biotechnology company developing a non-viral intracellular delivery platform based on liquid-liquid phase separation and biomolecular condensates.

Its lead product, BubbleFect, is a room-temperature-stable, non-lipid reagent designed for bench-top use without specialist equipment or cold-chain handling. The platform is used to deliver nucleic acids, proteins and gene-editing complexes into a range of cells, including hard-to-transfect primary and stem cells, while maintaining high cell viability.

Its applications span gene therapy, functional genomics and protein delivery.